We are live on ! Find out more
WDA

Wendell David Associates Portfolio holdings

AUM $947M
1-Year Est. Return 10.27%
This Fund
S&P 500
This Quarter Est. Return
-0.07%
1 Year Est. Return
+10.27%
3 Year Est. Return
+45.96%
5 Year Est. Return
+70.2%
10 Year Est. Return
+302.7%
AUM
$515M
AUM Growth
-$4.59M
Cap. Flow
-$2.21M
Cap. Flow %
-0.43%
Top 10 Hldgs %
30.55%
Holding
155
New
7
Increased
41
Reduced
45
Closed
6

Sector Composition

Rank Sector Weight
1 Healthcare 19.79%
2 Consumer Staples 17.41%
3 Technology 16.2%
4 Consumer Discretionary 10.11%
5 Industrials 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
126
Duke Energy
DUK
$97.8B
$369K 0.07%
5,197
MO icon
127
Altria Group
MO
$114B
$350K 0.07%
7,150
SEIC icon
128
SEI Investments
SEIC
$12.4B
$343K 0.07%
7,000
V icon
129
Visa
V
$684B
$343K 0.07%
5,115
+55
+1% +$3.73K
MNST icon
130
Monster Beverage
MNST
$94.3B
$322K 0.06%
14,400
NSC icon
131
Norfolk Southern
NSC
$75.4B
$317K 0.06%
3,640
TWX
132
DELISTED
Time Warner Inc
TWX
$314K 0.06%
3,610
NOC icon
133
Northrop Grumman
NOC
$77.1B
$305K 0.06%
1,920
EL icon
134
Estee Lauder
EL
$30.4B
$300K 0.06%
3,448
TROW icon
135
T. Rowe Price
TROW
$23.9B
$300K 0.06%
3,850
KIM icon
136
Kimco Realty
KIM
$17.2B
$297K 0.06%
13,500
ORCL icon
137
Oracle
ORCL
$374B
$273K 0.05%
6,819
AET
138
DELISTED
Aetna Inc
AET
$254K 0.05%
+2,000
New +$228K
SIRO
139
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
$245K 0.05%
2,450
-100
-4% -$9.6K
INGR icon
140
Ingredion
INGR
$6.27B
$240K 0.05%
+3,000
New +$241K
REGN icon
141
Regeneron Pharmaceuticals
REGN
$78.5B
$232K 0.05%
455
+10
+2% +$4.88K
WGL
142
DELISTED
Wgl Holdings
WGL
$224K 0.04%
4,150
DD
143
DELISTED
Du Pont De Nemours E I
DD
$219K 0.04%
3,776
BRK.A icon
144
Berkshire Hathaway Class A
BRK.A
$1.1T
$205K 0.04%
+1
New +$215K
UAA icon
145
Under Armour
UAA
$2.84B
$201K 0.04%
+4,884
New +$196K
CDK
146
DELISTED
CDK Global, Inc.
CDK
-55,019
Closed -$2.59M

Similar funds

Wendell David Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Wendell David Associates held 155 positions worth $515M, down 0.88% from $520M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Wendell David Associates's Q2 2015 filing shows 7 new, 41 increased, 45 reduced and 6 closed positions. Its largest new stake was Bristol-Myers Squibb: 14,359 shares worth $948K. The largest sale was SIGMA - ALDRICH CORP, an estimated $5.44M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Technology.

  • Wendell David Associates's largest Q2 2015 buy was Bristol-Myers Squibb: 14,359 shares worth $948K.
  • Wendell David Associates added most to Hain Celestial in Q2 2015, an estimated $1.15M increase.
  • Wendell David Associates's biggest Q2 2015 reduction was SIGMA - ALDRICH CORP, cutting an estimated $5.44M.
  • Wendell David Associates fully exited CDK Global, Inc. in Q2 2015, selling an estimated $2.59M.
  • Wendell David Associates's ten largest holdings make up 31% of its $515M portfolio in Q2 2015.
  • Wendell David Associates opened 7 new positions and closed 6 in Q2 2015.
  • Wendell David Associates's portfolio value fell 0.88% quarter-over-quarter to $515M.

Based on Wendell David Associates's 13F filing for Q2 2015, filed 20 Jul 2015.